PSA level <14
Showing 1 - 25 of >10,000
Prostate Cancer, Prostate Inflammation, PSA Trial in Albany (Ibuprofen or Naproxen, PSA test)
Recruiting
- Prostate Cancer
- +2 more
- Ibuprofen or Naproxen
- PSA test
-
Albany, New YorkAlbany Medical Center
Nov 29, 2022
Human Papillomavirus Infection, Vaccination Hesitancy Trial in Charlottesville (PSA Development, HPV vaccination focused social
Recruiting
- Human Papillomavirus Infection
- Vaccination Hesitancy
- PSA Development
- HPV vaccination focused social marketing campaign
-
Charlottesville, VirginiaUniversity of Virginia
May 5, 2023
Spinal Cord Injury, Acute, Spinal Cord Injury at C4 Level With Complete Lesion, Spinal Cord Injury at C5-C7 Level With Complete
Recruiting
- Spinal Cord Injury, Acute
- +2 more
- Neural precursor cells derived from human embryonic stem cell line
-
Suwon, Gyeonggido, Korea, Republic of
- +1 more
May 3, 2022
Melatonin and Response to Lithium
Not yet recruiting
- Bipolar Disorder I
- urine collection
- +2 more
-
Paris, Ile De France, FranceHôpital Fernand-Widal
May 19, 2023
Disease Activity Trial in Mansoura (Serum level of 14.0- 3.0- 3.0- ? protein and IL_.6)
Completed
- Disease Activity
- Serum level of 14.0- 3.0- 3.0- η protein and IL_.6
-
Mansoura, DK, EgyptMansoura University
May 4, 2022
Prostate Adenocarcinoma, PSA Level Greater Than 0.2, PSA Level Greater Than or Equal to Two Trial in Palo Alto (procedure,
No longer available
- Prostate Adenocarcinoma
- +4 more
- Computed Tomography
- +3 more
-
Palo Alto, CaliforniaStanford Cancer Institute Palo Alto
Jan 6, 2022
Prostatic Tumors Trial in Worldwide (Antiandrogen, Antiandrogen+docetaxel)
Active, not recruiting
- Prostatic Neoplasms
-
Copenhagen, Denmark
- +4 more
Aug 12, 2021
PSA Level Greater Than 0.03, PSA Progression, Stage I Prostate Adenocarcinoma AJCC (American Joint Committee on Cancer ) v7
Active, not recruiting
- PSA Level Greater Than 0.03
- +4 more
- Antiandrogen Therapy
- +2 more
-
Los Angeles, California
- +1 more
Oct 14, 2021
PSA Level Greater Than Two, Stage IV Prostate Adenocarcinoma AJCC v7 Trial in Duarte, South Pasadena (drug, radiation, other)
Active, not recruiting
- PSA Level Greater Than Two
- Stage IV Prostate Adenocarcinoma AJCC v7
- Bicalutamide
- +4 more
-
Duarte, California
- +1 more
Apr 4, 2022
AsseSSing Impact in pSoriatic Treatment
Recruiting
- Psoriatic Arthritis
- Questionnaire
-
Clermont-Ferrand, France
- +20 more
May 18, 2022
Prostate Adenocarcinoma, PSA Level Greater Than Ten, Stage IIB Prostate Cancer AJCC v8 Trial in Houston (Hyperpolarized Carbon C
Active, not recruiting
- Prostate Adenocarcinoma
- +9 more
- Hyperpolarized Carbon C 13 Pyruvate
- Magnetic Resonance Spectroscopic Imaging
-
Houston, TexasM D Anderson Cancer Center
Nov 16, 2022
Malocclusion Trial in Alexandria (low-level laser therapy applied on days 0, 3,7,14 & every 2 weeks, low-level laser therapy
Active, not recruiting
- Malocclusion
- low-level laser therapy applied on days 0, 3,7,14 & every 2 weeks
- low-level laser therapy applied every 3 weeks
-
Alexandria, EgyptAlexandria Faculty of Dentistry
Jun 11, 2021
Stage II Prostate Cancer, Stage IIA Prostate Cancer, Stage IIB Prostate Cancer Trial in United States (Internet-Based
Completed
- Stage II Prostate Cancer
- +7 more
- Internet-Based Intervention
- +5 more
-
Bellflower, California
- +27 more
Jan 2, 2022
Castration Levels of Testosterone, Castration-Resistant Prostate Carcinoma, Metastatic Prostate Carcinoma in the Soft Tissue
Withdrawn
- Castration Levels of Testosterone
- +8 more
-
Buffalo, New YorkRoswell Park Cancer Institute
Mar 31, 2021
Arthritis, Psoriatic Trial in Worldwide (Guselkumab, Placebo)
Metastatic Castration Resistant Prostate Cancer Trial in United States (VERU-111)
Active, not recruiting
- Metastatic Castration Resistant Prostate Cancer
-
Golden, Colorado
- +12 more
Mar 28, 2022
Progressive Metastatic Prostate Cancer Trial in Worldwide (Enzalutamide, Placebo)
Active, not recruiting
- Progressive Metastatic Prostate Cancer
- Enzalutamide
- Placebo
-
Beijing, China
- +46 more
Jan 13, 2023
Neuropathic Pain in Psoriatic Arthritis
Completed
- Psoriatic Arthritis
- painDETECT questionnaire
- +5 more
-
Istanbul, Fatih, TurkeyBezmialem Vakif University
Oct 4, 2022
Failure in Patients Undergoing Radiation Therapy for Localized
Active, not recruiting
- Prostate Cancer
- Radiation Toxicity
- medical chart review
- +4 more
-
San Francisco, CaliforniaUniversity of California, San Francisco
Dec 9, 2022
Medication Adherence in Psoriatic Arthritis
Completed
- Psoriatic Arthritis
- Disease activity in psoriatic arthritis (DAPSA)
- +5 more
-
Istanbul, Fatih, TurkeyBezmialem Vakif University
Aug 26, 2022
Prostate Cancer, Prostatic Tumor Trial in United States (abiraterone acetate in combination with prednisone)
Active, not recruiting
- Prostate Cancer
- Prostatic Neoplasm
- abiraterone acetate in combination with prednisone
-
Homewood, Alabama
- +44 more
Jan 17, 2023
Prostate Cancer Trial in New York (18F-Labeled Positron Emission Tomography (PET) Diagnostic Agent, PET MRI Imaging)
Not yet recruiting
- Prostate Cancer
- 18F-Labeled Positron Emission Tomography (PET) Diagnostic Agent
- PET MRI Imaging
-
New York, New YorkSmilow Comprehensive Prostate Cancer Center
Jan 9, 2023
Metastatic Castration-resistant Prostate Cancer, Prostate Cancer Metastatic, Castrate Resistant Prostate Cancer Trial in
Not yet recruiting
- Metastatic Castration-resistant Prostate Cancer
- +2 more
- 177Lu HTK03170
- 68Ga-HTK03149
-
Vancouver, British Columbia, CanadaBC Cancer
Nov 28, 2022
Tofacitinib PsA Initiators in the CorEvitas SpA Registry
Active, not recruiting
- Psoriatic Arthritis
-
New York, New YorkPfizer
Feb 8, 2022
Localized Prostate Carcinoma, Prostate Adenocarcinoma, Stage I Prostate Cancer AJCC v8 Trial in United States (Apalutamide,
Recruiting
- Localized Prostate Carcinoma
- +8 more
- Apalutamide
- Quality-of-Life Assessment
-
Tucson, Arizona
- +4 more
Jun 28, 2022